Pseudotumor Cerebri Support Group
Pseudotumor cerebri (PTC) is a neurological disorder that is characterized by increased intracranial pressure, in the absence of a tumor or other diseases affecting the brain or its lining. Diagnosis requires brain scans and lumbar puncture. Characteristic symptoms are headache, transient visual obscurations or transient visual loss in one or both eyes usually lasting...
I have no idea what my neuro will do. So far he has not been the model of flexibility. My new PCP might help, though. I haven't met her yet (1st appt in march), but we'll see.
There is an appeals process, but if you went through it, trust me, you'd know it. (It's a big fat unrelenting pain it the buttocks)
Please share your secret. Maybe it's something your doc did????? Or maybe it is specific to your employer's plan?
Here is what the drug is approved for. Anything else is considered experimental, as I understand it:
Drugdex recognizes the use of octreotide in the treatment of:
Bleeding esophageal varices with an appropriate adjunctive therapeutic intervention such as sclerotherapy
Hyperinsulinemia from severe refractory metastatic insulinoma as palliative treatment
Secretory diarrhea in patients with AIDS (acquired immunodeficiency syndrome) that has failed antibiotic/anti-motility therapy
Non-infective diarrhea:
chemotherapy-induced diarrhea
acute radiation-induced diarrhea
persistent ileostomy diarrhea
refractory familial amyloidotic polyneuropathy-induced diarrhea
The NCCN Drugs & Biologics Compendium recognizes the use of octreotide for additional uses beyond the FDA-approved labeling in the treatment of the following conditions (Refer to the NCCN Drugs & Biologics Compendium or NCCN Clinical Practice Guidelines for detailed recommendations):
Neuroendocrine tumors
Thymic Malignancies
http://www.bcbst.com/mpmanual/Octreotide_Systemic.htm